ArticleBMC pregnancy and childbirth2026
Placental mitochondrial DNA mutation-related oxidative stress underlies subsequent risk of adverse prognosis in sFGR twins.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundSelective fetal growth restriction (sFGR), a serious complication of monochorionic diamniotic (MCDA) twin pregnancies, typically results from unequal placental sharing, especially in type II sFGR. This condition is associated with an increased risk of intrauterine death and adverse neurological outcomes in one of the twin fetuses. Mitochondria play an important role in fetal development and mitochondrial DNA (mtDNA) mutations have been implicated in the pathogenesis of singleton FGR. Mutations in the mtDNA can lead tomitochondrial dysfunction, oxidative stress, and apoptosis. However, the role of increased placental mtDNA mutations in the pathogenesis of sFGR and their potential association with fetal growth and nervous system development remain unclear.
methodsIn this study, we characterized and compared the mtDNA mutation rate (MMR) in placentas from eight pairs of type II sFGR twins and eight pairs of uncomplicated MCDA twin controls (MCDA-C). Furthermore, peripheral blood mtDNA from the mothers of both the sFGR and MCDA-C twins was sequenced to determine the differences in mtDNA heteroplasmy between the mothers and twins. The overall MMR and mutation frequencies of individual genes were analyzed separately. Mitochondrial damage, oxidative stress, and apoptosis in the placenta were investigated by immunohistochemistry. In addition, correlations between MMR, birth weight, gestational age, and brain injury were evaluated to investigate the relationship between mitochondrial defects and clinical outcomes.
resultsWhole mitochondrial genome sequencing identified a significantly higher MMR in sFGR placentas than in MCDA-C placentas, especially in respiratory chain genes (MT-ND3, MT-CYB, complex III, and complex V). Maternal peripheral blood MMR did not differ significantly between sFGR and MCDA-C groups. However, analysis of mtDNA heteroplasmy revealed a significantly greater mother-twin heteroplasmy difference in sFGR pairs than in MCDA-C pairs. Immunohistochemical staining showed increased PARKIN-mitochondria colocalization, 8-OHdG and cleaved caspase 3 signals in sFGR placentas, particularly in placentas from growth-restricted smaller twins (sFGR-S), suggesting increased mitochondrial damage, cellular oxidative stress, and apoptosis. In the correlation analysis, the placental MMR was negatively correlated with birth weight and gestational age at delivery. Notably, the incidence of fetal brain injury, especially periventricular leukomalacia (PVL), was higher in sFGR twins and was positively associated with the MMR.
conclusionsPlacental mtDNA mutations and related oxidative stress are associated with adverse intrauterine environments in sFGR twins and may be associated with a higher frequency of fetal brain injury.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.